During the past decade, The Cancer Center of Hawaii-Liliha conducted 123 clinical trials. In the 10-year time frame, 123 clinical trials started and 83 clinical trials were completed, i.e. on average, 67.5% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 55 clinical trials were completed. i.e. 119.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Cancer Center of Hawaii-Liliha" #1 sponsor was "National Cancer Institute (NCI)" with 91 trials, followed by "SWOG Cancer Research Network" with 31 trials sponsored, "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "NRG Oncology" with 13 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Cancer Center of Hawaii-Liliha" #1 collaborator was "National Cancer Institute (NCI)" with 95 trials as a collaborator, "NRG Oncology" with 35 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "The Cancer Center of Hawaii-Liliha" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Recurrent Ovarian Carcinoma" (6 trials). Many other conditions were trialed in "The Cancer Center of Hawaii-Liliha" in a lesser frequency.

Most popular intervention types in "The Cancer Center of Hawaii-Liliha" are "Drug" (150 trials), "Other" (120 trials), "Biological" (69 trials), "Radiation" (47 trials) and "Procedure" (46 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (64 trials), "Quality-of-Life Assessment" (50 trials), "Carboplatin" (30 trials), "Questionnaire Administration" (30 trials) and "Paclitaxel" (29 trials). Other intervention names were less common.

The vast majority of trials in "The Cancer Center of Hawaii-Liliha" are 140 trials for "All" genders, 39 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "The Cancer Center of Hawaii-Liliha". undefined are not yet recruiting, 39 are recruiting, 91 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in The Cancer Center of Hawaii-Liliha, 6 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in The Cancer Center of Hawaii-Liliha, 4 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 108 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".

The Cancer Center of Hawaii-Liliha has several departments that took part in Clinical trials: "The Cancer Center of Hawaii-Pali Momi" - 118 trials